LNSR Q4 2023 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$12M+18.3% YoY

Gross Profit

$5M40.3% margin

Operating Income

-$3M-24.5% margin

Net Income

-$4M-32.4% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+23.6%

Cash Flow

Operating Cash Flow

-$480,000

Free Cash Flow

-$525,000

Stock-Based Comp.

$816,000

Balance Sheet

Total Assets

$70M

Total Liabilities

$36M

Stockholders' Equity

$33M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$10M	+18.3%
Gross Profit	$5M	$6M	-24.8%
Operating Income	-$3M	-$3M	-13.3%
Net Income	-$4M	-$2M	-57.7%

Revenue Segments

Product

$9M90%

Service

$1M10%

Geographic Segments

UNITED STATES

$8M78%

Europe

$1M11%

Asia Excluding South Korea

$896,0009%

KOREA, REPUBLIC OF

$223,0002%

Other Geographical Region

$102,0001%